Skip to main content
  • 808 Accesses

Abstract

Health expenditure is a particularly sensitive political issue for European Union countries. This is due to the continuing increase in expenditure, the considerable state spending devoted to this field and the questions that are raised on the effectiveness of this state spending. However, going beyond these general factors, there are significant disparities between the situations in the various countries. These reveal differences in the quality of the services provided and costs of these services. These differences may help to understand not only certain disparities in the economic attraction of the countries but also the geographical mobility of patients seeking healthcare. To explain the background in which European health systems operate, this report gives a few introductory remarks on the methodological choices, followed by an overall view of the situation regarding healthcare expenditure, indicating the current trends. The next section comments on the quality of the results obtained given the reimbursement rates provided for the public and the health situation as it stands. Finally, the report comments on the regulatory mechanisms that have been adopted to ensure better use of resources.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    For dental care, a ceramic crown (for which there is no set tariff) is half the price in Germany than in France where a large part of the cost is borne by complementary health insurance.

  2. 2.

    System of Health Accounts (SHA).

  3. 3.

    Calculated as purchasing power parity (ppp) to take account of differences in the cost of living between countries.

  4. 4.

    In the United Kingdom, the WANLESS report on “Securing our Future Health”, published in 2002, considered that the country was not investing sufficiently in healthcare and proposed a series of recommendations to increase total health expenditure to 10 % of GDP.

  5. 5.

    Unlike the cure approach, which covers all medical treatment used to cure disease and health problems, the care approach covers all that is related to prevention as well as support for and the attention paid to patients.

  6. 6.

    Such as allergies, diabetes and high blood pressure.

  7. 7.

    These three points were covered in detail in the first report by the Haut Conseil pour l’Avenir de l’Assurance Maladie in 2004.

  8. 8.

    These do not release subscribers from the obligation of contributing to finance the public system.

  9. 9.

    In this context this is “allocative efficiency”.

  10. 10.

    On the political front, poor use of resources can also result in a loss of confidence in state action and reduce willingness to pay taxes.

  11. 11.

    In 2010, Estonia and the Czech Republic were ranked 18th and 16th for life expectancy in the set of 21 European countries considered.

  12. 12.

    This concern with regulation is relatively long-established in Germany as Germany was one of the first European countries to implement a global health expenditure control policy. The Advisory Council for the Concerted Action in Health Care was set up for this purpose in 1977, bringing together all those involved in health.

  13. 13.

    Evaluated according to life expectancy.

  14. 14.

    It is known, for example; that housing, education and environment policies have a direct effect on public health.

  15. 15.

    The obstacles encountered in developing and financing the care related to dependency are a good illustration of these difficulties.

  16. 16.

    The private sector, which is present to some extent in all countries, falls naturally into this system.

  17. 17.

    The effectiveness of medical protocols remains however conditioned to a considerable extent by the way in which the information is made available to the medical corps and by the scope for independence that is left in the recommendations.

References

  • André JM, Del Sol M, Martin P, Turquet P (2011) L’assurance maladie privée en Europe: situation et tendances actuelles. Le Concours Médical 5:408–412

    Google Scholar 

  • Barilari A (2000) Le consentement à l’impôt. Presses de Sciences, Po

    Google Scholar 

  • Barro R, Sala I, Martin X (1995) Economic growth. McGraw Hill, London

    Google Scholar 

  • Commonwealth Fund (2011) Why not the best? Results from the national scorecard on US health system performance, octobre 2011

    Google Scholar 

  • Dormont B (2009) Les dépenses de santé, une augmentation salutaire? Editions rue d’Ulm, Paris

    Google Scholar 

  • DREES (2012) Les comptes nationaux de la santé 2011 Collection Etudes et Statistiques.

    Google Scholar 

  • Duriez M, Lequet-Slama D (1998) Les systèmes de santé en Europe PUF. Coll. Que sais-je?

    Google Scholar 

  • Grumbach K, Osmond D, Vranizan K, Jaffe D, Bindman AB (1998) Primary care physicians’ experience of financial incentives in managed care systems. New England Journal of Medicine 339(21):1518

    Article  Google Scholar 

  • Hartmann L (2003) L’accès aux soins de premiers recours en Europe. Revue française des affaires sociales 2-3:121–139

    Google Scholar 

  • HCAAM (2004) Rapport du Haut Conseil pour l’Avenir de l’Assurance Maladie

    Google Scholar 

  • Husson M (2004) La santé: un bien supérieur? Chronique internationale de l’IRES 91:134–150

    Google Scholar 

  • Jourdain-Menninger D, Lignot-Leloup M (2003) Comparaisons internationales sur la prévention sanitaire Rapport IGAS. La Documentation Française, Paris

    Google Scholar 

  • Le Pen C, Sicard D (2004) Santé: l’heure de choix. Desclée de Brouwer, Bilbao

    Google Scholar 

  • Le Pen C (2008) « La rentabilité collective des soins de santé ». Les Tribunes de la santé 2008/4(n° 21):23–30

    Article  Google Scholar 

  • Mintzberg H (1990) Le management: voyage au centre des organisations. Editions d’Organisation, Paris

    Google Scholar 

  • OCDE (2011) Panorama de la santé 2011 – Les indicateurs de l’OCDE, S 40–41

    Google Scholar 

  • OMS (2000) Rapport sur la santé dans le monde – Pour un système de santé plus performant

    Google Scholar 

  • Petignat PA (2009) Les guidelines sont-ils des standards à suivre? Revue médicale suisse 225:2271–2275

    Google Scholar 

  • Turquet P (2012) Réformes du financement des systèmes d’assurance maladie aux Pays-Bas, en Allemagne et en France: quelles conséquences en matière de couverture sociale et de redistribution ? Revue internationale de Sécurité sociale 65(1):33–56

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jean-Marie André .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

André, JM. (2014). Health Expenditure in the European Economy. In: Hennion, S., Kaufmann, O. (eds) Unionsbürgerschaft und Patientenfreizügigkeit Citoyenneté Européenne et Libre Circulation des Patients EU Citizenship and Free Movement of Patients. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-41311-7_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-41311-7_11

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-41310-0

  • Online ISBN: 978-3-642-41311-7

  • eBook Packages: Humanities, Social Science (German Language)

Publish with us

Policies and ethics